<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">ECONAZOLE NITRATE</span><br/>(e-kone'a-zole)<br/><span class="topboxtradename">Ecostatin <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Spectazole<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">antibiotic</span>; <span class="classification">antifungal</span><br/><b>Prototype: </b>Fluconazole<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>1% cream</p>
<h1><a name="action">Actions</a></h1>
<p>Synthetic imidazole derivative with broad antifungal spectrum of activity similar to that of miconazole. Exerts fungistatic
         action but may be fungicidal for certain microorganisms.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Active against dermatophytes (including <i>Trichophyton mentagrophytes, T. rubrum, T. tonsurans, Epidermophyton floccosum, Microsporum audouini, M. canis</i>), yeasts [e.g., <i>Candida albicans, Pityrosporum obiculare (tinea versicolor)</i>], and many other genera of fungi. Also appears to be active against some gram-positive bacteria (e.g., <i>Staphylococcus aureus, Streptococcus pyogenes, Corynebacterium diphtheriae</i>). Clinical improvement occurs within the first 12 wk of therapy.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Topically for treatment of <i>tinea pedis</i> (athlete's foot or ringworm of foot), <i>tinea cruris</i> ("jock itch" or ringworm of groin), <i>tinea corporis</i> (ringworm of body), <i>tinea versicolor</i>, and <i>cutaneous candidiasis</i> (moniliasis).
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Has been used for topical treatment of erythrasma and with corticosteroids for fungal or bacterial dermatoses associated with
         inflammation.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Safety during pregnancy (category C) or lactation is not established.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle"> <i>Tinea Cruris, Tinea Corporis, Tinea Pedis, Cutaneous Candidiasis</i> </span><br/><span class="rdage">Adult/</span><span class="rdage">Child:</span> <span class="rdroute">Topical</span> Apply sufficient amount to affected areas twice daily, morning and evening<br/><br/><span class="indicationtitle"> <i>Tinea Versicolor</i> </span><br/><span class="rdage">Adult:</span> <span class="rdroute">Topical</span> Apply sufficient amount to affected areas once daily<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Topical</span><br/><ul>
<li>Cleanse skin with soap and water and dry thoroughly before applying medication (unless otherwise directed by physician). Wash
            hands thoroughly before and after treatments.
         </li>
<li>Do not use occlusive dressings unless prescribed by physician.</li>
<li>Store at less than 30° C (86° F) unless otherwise directed.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Skin:</span> Burning, stinging sensation, pruritus, erythema. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> No clinically significant interactions established. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Minimal percutaneous absorption through intact skin; increased absorption from denuded skin. <span class="typehead">Peak:</span> 0.55 h. <span class="typehead">Elimination:</span> <a name="nursing"><span class="implictitle">Nursing Implications</span></a>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Use medication for the prescribed time even if symptoms improve and report to physician skin reactions suggestive of irritation
            or sensitization.
         </li>
<li>Notify physician if full course of therapy does not result in improvement. Diagnosis should be reevaluated.</li>
<li>Do not to apply the topical cream in or near the eyes or intravaginally.</li>
<li>Do not breast feed while using this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>